Amylyx Pharmaceuticals, Inc. (AMLX)
14.38
-0.34
(-2.28%)
USD |
NASDAQ |
Feb 25, 16:00
14.38
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Research and Development Expense (Quarterly) : 19.74M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biogen, Inc. | 434.00M |
| Cytokinetics, Inc. | 96.55M |
| Ionis Pharmaceuticals, Inc. | 217.13M |
| MediciNova, Inc. | 1.543M |
| ACADIA Pharmaceuticals, Inc. | 87.83M |